Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer (HealthDay)
Date : 2008 03 11 Category : Health
HealthDay - TUESDAY, March 11 (HealthDay News) -- There's good news for the
60 percent of women with breast cancer whose malignancies are
estrogen-driven: Researchers say taking the aromatase inhibitor (AI) drug
letrozole (Femara) can cut risk of a recurrence by more than half.